PLEURAL EFFUSION (PE) - an accumulation of fluid between the pleura, the layered membranes lining the outer surface of the lungs and the chest cavity. Small amounts of pleural fluid lubricate the pleura for optimum movement and efficiency of the lungs in the work of breathing. Pleural effusion, where there is a larger than normal amount of pleural fluid, can make breathing more difficult, can cause cough and shortness of breath along with rapid breathing. Pleural effusion is usually caused by disruption of the normal pressure in the lung and usually represents an underlying disease process. Several disease states can alter the normal factors that keep fluid from accumulating, including congestive heart failure, inflammation of the pleura, cancer, tuberculosis, pneumonia, drug reactions, sarcoidosis, asbestosis and collagen-vascular diseases.
The cause of pleural effusion can usually be determined by removing a sample of the fluid by thoracentesis. Thoracentesis is a procedure, often performed in the physician’s office, in which a needle is inserted between the ribs into the chest cavity to obtain the pleural fluid. A local anesthetic is used. Several lab studies are routinely performed on the fluid to determine that cause or the underlying disease process.
PNEUMONIA - an infection of the lungs caused by a viral, bacterial or fungal infection. Pneumonia is a very common, often serious illness that affects about 3-4 million people each year in the United States alone. Patients present with cough, sputum, chest pain, fever, shortness of breath and there is usually an abnormality on a simple chest x-ray. Pneumonia is an important cause of death.
PPD - tuberculin purified protein derivative is a test to determine if a person has been exposed to tuberculosis. This may be referred to as a TB skin test. The PPD is injected just under the upper layers of the skin on the forearm. If someone has been exposed to tuberculosis or has active tuberculosis the tested area will react and become hard and raised wth 48 - 72 hours. If the test is positive, a chest x-ray is usually done to determine if there is active disease. Medications must be taken daily for a period of time if there is active disease, or until it can be proven there is no tuberculosis infection.
PULMONARY EMBOLUS - blockage of a blood vessel in the lungs by blood clot, fat, air or a group of tumor cells. Blood clots that form in the veins in the leg (deep vein thrombosis, DVT) or pelvis and move to the lungs are most often the cause of pulmonary emboli. PE is preventable and when it occurs is treated by blood thinners.
Factors that increase the chance of having a pulmonary embolus include: prolonged inactivity such as bed rest; sitting for long periods of time on trips; oral contraceptive use; childbirth; serious burns; stroke; heart surgery; massive trauma; fractures of the femur or hips; and certain clotting disorders.
PULMONARY FIBROSIS - thickening and scarring of the lungs. This can occur after exposure to asbestos, silicates and other materials or most often without any known exposures or causes. This is a serious disorder that occurs in older individuals and presents with cough and short of breath with exertion. The process is typically progressive over 1-2 years, patients have “crackling” noises in the chest, and have typical abnormalities on chest x-rays and CT scans. Sometimes lung biopsies are performed and treatments are attempted with “immunosuppression” using prednisone and other medications. Most often these therapies are not particularly effective and the disease progresses and patients require home oxygen therapy. There is a lot of research ongoing in this disease.
PULMONARY FUNCTION TESTING (PFT) - types of testing that measure a specific function of the lungs or documents specific volume of air in the lungs. The tests provide information about a diagnosis and can also be used to monitor effectiveness of medications. PFTs are widely used by physicians to help measure lung function to diagnose lung disease. Several different types of tests including simple spirometry, lung volume measurement, diffusion capacity, arterial blood gases, and exercise studies can all be described by the term PFTs. These studies can be performed in the office or in a hospital setting. The active participation and cooperation of the patient is very important in getting useful information.
PULMONARY HYPERTENSION - narrowing of the pulmonary arterioles within the lung. The narrowing of the arteries creates resistance and increases the work load of the heart. Over time the heart becomes enlarged from pumping blood against the resistance. Symptoms include shortness of breath, weakness, fatigue and chest pain. The goal is to treat the cause of the pulmonary hypertension and control the symptoms. Pulmonary hypertension can occur with several different medical conditions (i.e. heart disease); disease of other parts of the body, or may occur in isolation (i.e. primary). There are several new medications that are helping patients with pulmonary hypertension.
PULMONARY REHABILITATION – individuals with lung disease may benefit from rehabilitation therapy to help improve lung function, exercise tolerance, help decrease how often a person gets sick and improve quality of life and life span. A person who participates in pulmonary rehabilitation will receive education about his or her lung disease, therapy and monitoring to ensure safety.
SARCOIDOSIS - a disease of unknown cause that most often affects the lungs. The disease is characterized by inflammation and formation of clusters of certain types of cells call granulomas, which represent the hallmark of the disease. The types of cells include macrophages, multinucleated giant cells and lymphocytes. These can occur in many organs but most commonly lymph nodes, lungs, skin, eyes, liver or other tissues in the body. The cause of sarcoidosis is unknown and its effect varies with each individual. For example, some individuals with sarcoidosis may have lung involvement only, others may have liver or some other tissue involvement. The disease maybe very mild sometimes (i.e. patients do not even know they have it) whereas other situations the disease can produce symptoms (due to the part of the body that is affected) and produce organ failure and occasionally death.
Sarcoidosis is more common among African Americans and Northern European Caucasians. There are more women than men of African heritage affected by this disease. There is active research into sarcoidosis in the Pulmonary and Critical Care Medicine Division at Brody School of Medicine at ECU. Environment, genetic predisposition, and immune response to infections are some possible causes of this disease. There are newer therapies beyond corticosteroids that are being investigated as possible therapy.
For more information about sarcoidosis and its treatments, click here.
SLEEP APNEA – Apnea is a lack of breathing and sleep apnea is the disorder of interrupted breathing while sleeping. The time without breathing in someone with sleep apnea may last 10 seconds to over one minute and happen many times in one hour and throughout the night. This is a serious medical problem, not only because a person with sleep apnea is at risk of falling asleep while driving or operating equipment and harming self and others, but also because it makes the heart and blood vessels work harder. This leads to hypertension, pulmonary hypertension and heart failure. Obstructive sleep apnea is the most common type and occurs when there is partial blockage of the upper airway. Someone with obstructive sleep apnea may recall waking up abruptly during the night gasping as they take a breath after an episode of apnea. However, often the person does not fully wake up or remember waking up. Another type of sleep apnea that is much less common is central sleep apnea that occurs because the brain does not signal the body to breath like it normally does.
A polysomnogram, or sleep study, can be done to determine if a person has sleep apnea and what kind of sleep apnea. If someone does have sleep apnea, the second part of the polysomnogram is to determine how to best treat it. CPAP (continuous positive air pressure or BiPAP (bi-level positive air pressure) are two methods that correct sleep apnea. The type of device and setting of air flow is determined during the second phase of the study. Sometimes surgery is recommended to remove tissue from the soft palate and area surrounding the palate. If someone with sleep apnea is overweight, weight loss can often eliminate sleep apnea.
SMOKING CESSATION – Quitting smoking can be a very difficult challenge. Smoking is the greatest cause of lung cancer, as well as chronic obstructive pulmonary diseases – emphysema and chronic bronchitis. Over time, lung damage can be so severe that a person must use oxygen. Each person responds differently to different methods of quitting smoking and often a combination of methods is most successful. It is important to discuss the various methods with your physician.
To learn more about quitting smoking, click here.
SPIROMETRY – a type of PFT, is a painless study wherein the patient initially takes a deep breath and then rapidly blows out the air in the chest into a measuring device known as a spirometer. The device measures exhaled volume and airflow from the lungs that is frequently used to evaluate lung function. This is one part of a PFT used in people with obstructive lung diseases such as asthma, COPD, or cystic fibrosis.
THORACENTESIS - a procedure to remove fluid from the pleural space, the area between the chest wall and lungs. It can be done to help diagnose the cause of a pleural effusion, or abnormal collection of fluid. If the collection of fluid is very large, thoracentesis can also be used to remove the fluid, which can improve breathing by relieving pressure caused by the fluid pressing against the lung. This procedure can be done in the pulmonologist's office. A chest x-ray is taken before the procedure so the physician can determine where the fluid is. The area where the needle will be inserted is cleaned and numbing medication is used before inserting the needle. A person having this procedure usually sits upright, leaning forward slightly, resting on some type of support such as an examination table. Afterward, the person can rest quietly for about one hour. Occasionally the needle may cause a small puncture in the lung and there may be some collapse of part of the lung. If this happens, breathing may become difficult and chest pain may develop. Chest x-ray can be done to determine how much the lung has been affected. Minimal lung collapse will most often get better in time with no intervention.
For more information about this and other procedures, please click here.